Back to Search
Start Over
Comparison of Visual Outcomes in Coats' Disease: A 20-Year Experience.
- Source :
-
Ophthalmology [Ophthalmology] 2017 Sep; Vol. 124 (9), pp. 1368-1376. Date of Electronic Publication: 2017 Apr 28. - Publication Year :
- 2017
-
Abstract
- Purpose: To report differences in visual acuities among patients with Coats' disease who sought treatment at a tertiary care university-based practice.<br />Design: Single-center retrospective cohort study.<br />Participants: Patients with Coats' disease diagnosed clinically, angiographically, or both from 1995 through 2015.<br />Methods: Patients were divided into 2 groups based on date of presentation: decade 1 (1995-2005) and decade 2 (2006-2015).<br />Main Outcome Measures: Visual acuity (VA).<br />Results: Thirty-nine eyes of 39 patients were included with 19 eyes presenting in decade 1 and 20 eyes presenting in decade 2. Three patients demonstrated bilateral disease, but only the worse eye was included for analysis. Forty-seven percent of eyes in decade 1 demonstrated advanced stages of disease (stage 3B or worse) compared with 20% of eyes in decade 2. There was a trend for the mean initial presenting VA (±standard deviation) for decade 1 eyes to be worse (2.05±1.29 logarithm of the minimum angle of resolution [logMAR]) than for decade 2 eyes (1.45±0.99 logMAR; P = 0.1). From initial to final follow-up visit, mean VA also worsened for decade 1 eyes (P = 0.03), but remained stable for decade 2 eyes (P = 1.0). At the end of follow-up, there was a trend for mean VA for decade 1 eyes (2.28±1.17 logMAR) to be worse than for decade 2 eyes (1.60±1.15 logMAR; P = 0.07). Eight eyes were observed initially in decade 1 compared with 1 eye in decade 2, and only 1 of the observed eyes (in decade 2) developed painful glaucoma requiring enucleation. Decade 2 eyes had a higher average number of procedures per eye (6.5±4.9) compared with decade 1 eyes (1.4±1.7; P < 0.001).<br />Conclusions: The earlier presentation of disease in decade 2 suggests improvements in disease detection over time. Furthermore, there was a trend for eyes to have better final VA in this decade. This is due to a combination of factors, including earlier presentation of disease, fewer eyes being observed without treatment, and eyes, when treated, receiving a higher number of procedures.<br /> (Copyright © 2017 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.)
- Subjects :
- Adolescent
Angiogenesis Inhibitors therapeutic use
Bevacizumab therapeutic use
Child
Child, Preschool
Cohort Studies
Disease Progression
Female
Fluorescein Angiography
Follow-Up Studies
Humans
Infant
Intravitreal Injections
Laser Coagulation
Male
Retinal Telangiectasis diagnosis
Retinal Telangiectasis drug therapy
Retrospective Studies
Vascular Endothelial Growth Factor A antagonists & inhibitors
Retinal Telangiectasis physiopathology
Visual Acuity physiology
Subjects
Details
- Language :
- English
- ISSN :
- 1549-4713
- Volume :
- 124
- Issue :
- 9
- Database :
- MEDLINE
- Journal :
- Ophthalmology
- Publication Type :
- Academic Journal
- Accession number :
- 28461016
- Full Text :
- https://doi.org/10.1016/j.ophtha.2017.03.051